Sven Becker

12.3k citations
321 papers · 8.2k indexed · h-index 47

Sven Becker

296 papers receiving 8.0k citations

Peers

Sven Becker
Comparison fields: 5 of 180
  • Oncology 2.7k
  • Otorhinolaryngology 417
  • Immunology and Allergy 531
  • Cancer Research 1.2k
  • Immunology 1.4k
Replace Vincent Cogliano with:
Vincent Cogliano France
Kingston H. G. Mills Ireland
Philip Rosenstiel Germany
Renée A. Desmond United States
Hiroshi Miyamoto United States
Chang‐Hoon Kim South Korea
Ling Zhang China
Yasushi Sasaki Japan
William E. Miller United States
Miriam F. Moffatt United Kingdom
Sven Becker relative to Vincent Cogliano France Vincent Cogliano's profile →
Citations per field
00.5×6.3×
Vincent Cogliano · 1×
Citations per year

Countries citing papers authored by Sven Becker

Since Specialization
Citations

This map shows the geographic impact of Sven Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Becker more than expected).

Fields of papers citing papers by Sven Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Becker. The network helps show where Sven Becker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sven Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sven Becker Line = papers co-authored together Sven Becker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20240
4 20241
5 20241
6 20231
7 202318
8 20236
9 202116
10 202113
11 202122
12 20189
13 201867
14 20157
15 201312
16 201133
17 2009193
18
Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
200522
19 200220
20 2001215

About Sven Becker

Sven Becker is a scholar working on Immunology and Allergy, Otorhinolaryngology and Dermatology, having authored 321 papers that have together received 8.2k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (56 papers), Asthma and respiratory diseases (41 papers), Cancer Cells and Metastasis (31 papers), Sinusitis and nasal conditions (24 papers), Breast Cancer Treatment Studies (17 papers), Cancer Genomics and Diagnostics (15 papers), Ovarian cancer diagnosis and treatment (15 papers) and Dermatology and Skin Diseases (15 papers). The work is most often cited by research in Oncology (2.7k citations), Otorhinolaryngology (417 citations) and Immunology and Allergy (531 citations). Sven Becker has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Klaus Strebhardt, Tanja Fehm, D. Wallwiener, Torsten Tonn, Ranadip Mandal, Dirk Schwabe, Tobias L. Lenz, Ruth Esser, Robert Hanner and Anneliese Ernst. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, Breast Cancer Research and Treatment, Cancers, PLoS ONE and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026